| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Microbiology and
Cancer Research Unit, Faculty of Medicine, The University of Newcastle, Newcastle, New South Wales, Australia; and
Department of Immunoregulation, Research Institute of Microbial Diseases, Osaka University, Suita, Osaka, Japan
Decay-accelerating factor (DAF), a widely expressed membrane complement-regulatory protein, is utilized as a cellular receptor by many human enteric pathogens. We show here that the binding of two enteroviruses to individual short consensus repeats (SCR) of DAF on the cell surface is greatly augmented by mAb binding to an alternate SCR: Coxsackievirus A21 binding to the SCR1 of DAF is increased by Ab binding to SCR3 and, conversely, Echovirus 7 binding to SCR3 is enhanced severalfold by Ab binding to SCR1. These Ab-induced increases in viral binding also resulted in increased viral infectivity. Using purified soluble DAF in a solid phase assay it was found that Ab binding to SCR1 is increased greatly in the presence of an Ab against SCR3 and, reciprocally, Ab against SCR1 greatly increases Ab binding to SCR3. In contrast to the results obtained with the larger viral particles, however, this reciprocal Ab-induced enhancement of binding is not seen when measuring Ab binding to membrane-bound DAF SCR on the cell surface. These findings provide a possible explanation for functional differences between membrane-bound and soluble DAF with implications for a potential role for DAF-binding molecules in regulating DAF function. This is the first demonstration of enhancement of viral infectivity mediated by Ab against the viral receptor.
This article has been cited by other articles:
|
|
 |
|
  D. P. O'Brien, D. A. Israel, U. Krishna, J. Romero-Gallo, J. Nedrud, M. E. Medof, F. Lin, R. Redline, D. M. Lublin, B. J. Nowicki, et al. The Role of Decay-accelerating Factor as a Receptor for Helicobacter pylori and a Mediator of Gastric Inflammation J. Biol. Chem., May 12, 2006; 281(19): 13317 - 13323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Servin Pathogenesis of Afa/Dr Diffusely Adhering Escherichia coli Clin. Microbiol. Rev., April 1, 2005; 18(2): 264 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Johansson, L. Xing, R. H. Cheng, and D. R. Shafren Enhanced Cellular Receptor Usage by a Bioselected Variant of Coxsackievirus A21 J. Virol., November 15, 2004; 78(22): 12603 - 12612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Newcombe, L. G. Beagley, D. Christiansen, B. E. Loveland, E. S. Johansson, K. W. Beagley, R. D. Barry, and D. R. Shafren Novel Role for Decay-Accelerating Factor in Coxsackievirus A21-Mediated Cell Infectivity J. Virol., November 15, 2004; 78(22): 12677 - 12682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Williams, Y. Chaudhry, I. G. Goodfellow, S. Lea, and D. J. Evans Interactions of decay-accelerating factor (DAF) with haemagglutinating human enteroviruses: utilizing variation in primate DAF to map virus binding sites J. Gen. Virol., March 1, 2004; 85(3): 731 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Newcombe, E. S. Johansson, G. Au, A. M. Lindberg, R. D. Barry, and D. R. Shafren Enterovirus Capsid Interactions with Decay-Accelerating Factor Mediate Lytic Cell Infection J. Virol., February 1, 2004; 78(3): 1431 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Newcombe, P. Andersson, E. S. Johansson, G. G. Au, A. M. Lindberg, R. D. Barry, and D. R. Shafren Cellular receptor interactions of C-cluster human group A coxsackieviruses J. Gen. Virol., November 1, 2003; 84(11): 3041 - 3050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Greenstone, F. Santoro, P. Lusso, and E. A. Berger Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function J. Biol. Chem., October 11, 2002; 277(42): 39112 - 39118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Stuart, H. E. Eustace, T. A. McKee, and T. D. K. Brown A Novel Cell Entry Pathway for a DAF-Using Human Enterovirus Is Dependent on Lipid Rafts J. Virol., August 12, 2002; 76(18): 9307 - 9322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Hasan, E. Pawelczyk, P. T. Urvil, M. S. Venkatarajan, P. Goluszko, J. Kur, R. Selvarangan, S. Nowicki, W. A. Braun, and B. J. Nowicki Structure-Function Analysis of Decay-Accelerating Factor: Identification of Residues Important for Binding of the Escherichia coli Dr Adhesin and Complement Regulation Infect. Immun., August 1, 2002; 70(8): 4485 - 4493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Shafren, D. J. Dorahy, R. F. Thorne, and R. D. Barry Cytoplasmic interactions between decay-accelerating factor and intercellular adhesion molecule-1 are not required for coxsackievirus A21 cell infection J. Gen. Virol., April 1, 2000; 81(4): 889 - 894. [Abstract] [Full Text]
|
|
|
|
|
|
A. Pasch, J.-H. Küpper, A. Wolde, R. Kandolf, and H.-C. Selinka Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3 J. Gen. Virol., December 1, 1999; 80(12): 3153 - 3158. [Abstract] [Full Text]
|
|
|
|
|
|
D. R. Shafren, J. Gardner, V. H. Mann, T. M. Antalis, and A. Suhrbier Picornavirus Receptor Down-Regulation by Plasminogen Activator Inhibitor Type 2 J. Virol., September 1, 1999; 73(9): 7193 - 7198. [Abstract] [Full Text]
|
|
|
|
|
|
T. C. Marlovits, C. Abrahamsberg, and D. Blaas Soluble LDL Minireceptors. MINIMAL STRUCTURE REQUIREMENTS FOR RECOGNITION OF MINOR GROUP HUMAN RHINOVIRUS J. Biol. Chem., December 11, 1998; 273(50): 33835 - 33840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Shafren Viral Cell Entry Induced by Cross-Linked Decay-Accelerating Factor J. Virol., November 1, 1998; 72(11): 9407 - 9412. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
